Rangeley Capital »

180 Life Sciences Corp shares owned by Rangeley Capital

Quarter-by-quarter ownership of 180 Life Sciences Corp (ETHZ) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in 180 Life Sciences Corp

Tip: Access up to 7 years of quarterly data

All positions including 180 Life Sciences Corp held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 180 Life Sciences Corp by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 10k 2.41

More positions owned by Rangeley Capital

Delek Us Holdings (DK)
Calumet (CLMT)
Arvinas Ord (ARVN)
Prothena Corp SHS (PRTA)
Wideopenwest (WOW)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Yext (YEXT)
Keros Therapeutics (KROS)
Arbutus Biopharma (ABUS)
Seaport Entmt Group Common Stock (SEG)
Berto Acquisition Corp Ord Shs (TACO)
Charter Communications Inc N Cl A (CHTR)
Full House Resorts (FLL)
Surgery Partners (SGRY)
Core Scientific *w Exp 01/23/202 (CORZW)

View all positions for Rangeley Capital

Top funds holding 180 Life Sciences Corp

Citadel Advisors
Steadfast Capital Management
Susquehanna International
Diameter Capital Partners
Woodline Partners
BlackRock
Vanguard Group
Founders Fund Growth Management
Jane Street
Geode Capital Management
Saba Capital Management
Charles Schwab Investment Management
Renaissance Technologies
State Street Corporation
Cantor Fitzgerald, L. P.

View all funds holding 180 Life Sciences Corp